Pharma: Other News To Note
Wednesday, March 27, 2013
GlaxoSmithKline plc, of London, and the Texas A&M University System said the Department of Health and Human Services approved the establishment of a $91 million influenza-vaccines manufacturing facility as the anchor for the Center for Innovation in Advanced Development and Manufacturing in Bryan-College Station, Texas.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.